Population-based study of ovarian cancer in Cote d'Or: prognostic factors and trends in relative survival rates over the last 20 years

被引:8
作者
Hamidou, Zeinab [1 ,2 ]
Causeret, Sylvain [1 ]
Dabakuyo, Tienhan S. [1 ,2 ]
Gentil, Julie [1 ,2 ]
Arnould, Laurent [1 ]
Roignot, Patrick [3 ]
Altwegg, Thierry [4 ]
Poillot, Marie-Laure [1 ]
Bonnetain, Franck [2 ,5 ]
Arveux, Patrick [1 ,2 ]
机构
[1] Ctr Georges Francois Leclerc, Registre Canc Sein & Autres Canc Gynecol Cote Or, Dijon, France
[2] Univ Bourgogne, EA 4184, F-21000 Dijon, France
[3] Ctr Pathol, F-21000 Dijon, France
[4] Ctr Radiotherapie Parc, F-21000 Dijon, France
[5] Ctr Georges Francois Leclerc, Unite Biostat & Epidemiol, F-21079 Dijon, France
关键词
FOLLOW-UP; WESTERN SWEDEN; ONCOLOGY-GROUP; STAGE-III; PATTERNS; PROGRESS; WOMEN; CHEMOTHERAPY; IMPROVEMENT; CARCINOMA;
D O I
10.1186/1471-2407-10-622
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The aim of this population-based study was to assess independent prognostic factors in ovarian cancer using relative survival (RS) and to investigate changes in RS rates from 1982 to 2005. Methods: Data on 748 patients with ovarian cancer were provided by the Cote d'Or gynaecologic cancer registry. The RS was estimated using a generalized linear model with a Poisson error structure. Relative survival and its 95% confidence interval (CI) were described at the following specific time points 1, 3 and 5 years. The effect of prognostic factors on survival was assessed with multivariate analyses of RS. Results: The median follow-up was 12 years. The RS rates at 1, 3 and 5 years were 81%, 55% and 44%, respectively. As compared with the period 1982-1989, an improvement in survival was found for the period 19982005: HR = 0.52[0.40-0.67]. Women who lived in urban areas had better RS: HR = 0.82[0.67-0.99]. Patients with epithelial types of ovarian cancer other than mucinous or endometrioid cancer had worse RS than those with serous histology. Age = 70 years was associated with lower survival. Conclusions: Period of diagnosis, stage at diagnosis, histology, place of residence and age were independent prognostic factors for survival in ovarian cancer. An improvement in the survival rate was observed after 1998 but a significant improvement was limited to advanced stage cancers.
引用
收藏
页数:8
相关论文
共 24 条
[1]   A Population-Based 5-Year Cohort Study Including All Cases of Epithelial Ovarian Cancer in Western Sweden: 10-Year Survival and Prognostic Factors [J].
Akeson, Margareth ;
Jakobsen, Anne-Marie ;
Zetterqvist, Britt-Marie ;
Holmberg, Erik ;
Braennstroem, Mats ;
Horvath, Gyoergy .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (01) :116-123
[2]   Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: A population-based cohort study of all patients in western Sweden with long-term follow-up [J].
Akeson, Margaretha ;
Zetterqvist, Britt-Marie ;
Dahllof, Kalle ;
Brannstrom, Mats ;
Horvath, Gyorgy .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2008, 87 (12) :1343-1352
[3]   Ovarian cancer: Changes in patterns at diagnosis and relative survival over the last three decades [J].
Barnholtz-Sloan, JS ;
Schwartz, AG ;
Qureshi, F ;
Jacques, S ;
Malone, J ;
Munkarah, AR .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (04) :1120-1127
[4]   Cancer incidence and mortality in France over the period 1980-2005 [J].
Belot, A. ;
Grosclaude, P. ;
Bossard, N. ;
Jougla, E. ;
Benhamou, E. ;
Delafosse, P. ;
Guizard, A. -V. ;
Molinie, F. ;
Danzon, A. ;
Bara, S. ;
Bouvier, A. -M. ;
Tretarre, B. ;
Binder-Foucard, F. ;
Colonna, M. ;
Daubisse, L. ;
Hedelin, G. ;
Launoy, G. ;
Le Stang, N. ;
Maynadie, M. ;
Monnereau, A. ;
Troussard, X. ;
Faivre, J. ;
Collignon, A. ;
Janoray, I. ;
Arveux, P. ;
Buemi, A. ;
Raverdy, N. ;
Schvartz, C. ;
Bovet, M. ;
Cherie-Challine, L. ;
Esteve, J. ;
Remontet, L. ;
Velten, M. .
REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2008, 56 (03) :159-175
[5]   Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis [J].
Bristow, RE ;
Tomacruz, RS ;
Armstrong, DK ;
Trimble, EL ;
Montz, FJ .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1248-1259
[6]   Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: What prognostic factors are important? [J].
Chan, JK ;
Loizzi, V ;
Lin, YG ;
Osann, K ;
Brewster, WR ;
DiSaia, PJ .
OBSTETRICS AND GYNECOLOGY, 2003, 102 (01) :156-161
[7]   Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers [J].
Chan, John K. ;
Teoh, Deanna ;
Hu, Jessica M. ;
Shin, Jacob Y. ;
Osann, Kathryn ;
Kapp, Daniel S. .
GYNECOLOGIC ONCOLOGY, 2008, 109 (03) :370-376
[8]   Patterns and progress in ovarian cancer over 14 years [J].
Chan, John K. ;
Cheung, Michael K. ;
Husain, Amreen ;
Teng, Nelson N. ;
West, Dee ;
Whittemore, Alice S. ;
Berek, Jonathan S. ;
Osann, Kathryn .
OBSTETRICS AND GYNECOLOGY, 2006, 108 (03) :521-528
[9]   Population-based cancer survival in Singapore, 1968 to 1992: An overview [J].
Chia, KS ;
Du, WB ;
Sankaranarayanan, R ;
Sankila, R ;
Seow, A ;
Lee, HP .
INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (01) :142-147
[10]   Patterns of chemotherapy use for women with ovarian cancer: A population-based study [J].
Cress, RD ;
O'Malley, CD ;
Leiserowitz, GS ;
Campleman, SL .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (08) :1530-1535